KMG Fiduciary Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,346
| Closed | -$211K | – | 216 |
|
|
2022
Q1 | $211K | Sell |
2,346
-285
| -11% | -$25.6K | 0.03% | 198 |
|
|
2021
Q4 | $295K | Sell |
2,631
-20
| -0.8% | -$2.24K | 0.05% | 172 |
|
|
2021
Q3 | $333K | Sell |
2,651
-15
| -0.6% | -$1.88K | 0.06% | 161 |
|
|
2021
Q2 | $361K | Sell |
2,666
-717
| -21% | -$97.1K | 0.06% | 152 |
|
|
2021
Q1 | $459K | Buy |
3,383
+830
| +33% | +$113K | 0.09% | 129 |
|
|
2020
Q4 | $359K | Sell |
2,553
-133
| -5% | -$18.7K | 0.08% | 134 |
|
|
2020
Q3 | $299K | Hold |
2,686
| – | – | 0.07% | 128 |
|
|
2020
Q2 | $301K | Buy |
2,686
+20
| +0.8% | +$2.24K | 0.08% | 113 |
|
|
2020
Q1 | $206K | Buy |
2,666
+261
| +11% | +$20.2K | 0.07% | 123 |
|
|
2019
Q4 | $229K | Buy |
+2,405
| New | +$229K | 0.07% | 117 |
|
|
2019
Q3 | – | Sell |
-2,792
| Closed | -$245K | – | 120 |
|
|
2019
Q2 | $245K | Buy |
2,792
+60
| +2% | +$5.27K | 0.09% | 99 |
|
|
2019
Q1 | $247K | Buy |
+2,732
| New | +$247K | 0.09% | 102 |
|